Blog

12 Jul

A concise BioPharma brief on MOTS-c research, this week’s GLP-1 neurology signal, and peptide study interpretation.

12 Jul

BPC-157 ischemia research: 2026 Sci Rep vascular protection data, ischemia-reperfusion mechanisms, comparisons, limits, and FAQ.

09 Jul

RFK peptide reclassification 2026 explained: FDA compounding list context, research impact, evidence limits, compliance, and FAQ.

05 Jul

A concise BioPharma brief on BPC-157 cognitive research, MOTS-c catalog context, and peptide study interpretation.

05 Jul

BPC-157 cholinergic mechanisms in 2026: AChE research, cognitive pathway questions, comparisons, evidence limits, and FAQ.

02 Jul

MOTS-c fertility research in 2026: spermatogenesis, SLC7A11, ferroptosis suppression, comparisons, and research-only FAQ.

28 Jun

MOTS-c inflammation research trend, product highlight, and a study-design tip for mitochondrial peptide literature review.

28 Jun

MOTS-c cardiac inflammation research: June 2026 diabetic-model evidence, metabolic signaling limits, comparisons, and FAQ.

25 Jun

BPC-157 acetylcholinesterase research in 2026: new mechanism study, brain research angle, comparisons, and research-only FAQ.

14 Jun

RAD-140 Research UpdateFor research purposes only. Not for human consumption.1. Weekly research signal Oral GLP-1 research is still...